« UK - Nokia v. IPCom | Main | UK - Apimed Medical Honey v. Brightwake Limited »

20/01/2012

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The combination of Clopidogrel busulfate and aspirin seemed to lack inventive step as it is obvious for a person skilled in the art to combine these two entities for use as composition. An unexpected and synergisitic properties as a result of combination may pose an advantage to the patentability.

The comments to this entry are closed.

Categories

EPLAW Patent Blog sponsors:

Enter your email address:

Delivered by FeedBurner